Skip to main content

Advertisement

Table 2 Characteristics of study participants on basis of kidney disease status

From: Prevalence and risk factors of kidney disease in urban Karachi: baseline findings from a community cohort study

  No kidney disease Mild kidney disease Moderate kidney disease Total cohort p value
Age (years); Median (IQR) 30 (22–40)a 30 (19.75-54.25)b 52.5 (46–64.75)a,b,c 31 (22–43) 0.000**
n 292 30 28 350
BMI (kg/m2); Median (IQR) 21 (18.6-25.3)a 21.8 (18.5-27.4)b 23.9 (20.4-28.6)c 21.33 (18.64-25.5) 0.09
n 290 30 28 348
SBP (mmHg); Median (IQR) 118.7 (110.3-128.0)a 123.7 (109.6-130.0)b 133.0 (122.3-158.0)a,b,c 119.67 (110.67-129.67) 0.000**
n 291 30 28 349
DBP (mmHg); Median (IQR) 75.0 (69.0-82.3)a 77.5 (70.5-82.7)b 83.7 (73.9-96.4)a,c 75.7 (69.3-83.0) 0.004*
n 291 30 28 349
Creatinine (mg/dl); Median (IQR) 0.9 (0.8-1)a 0.9 (0.8-1.1)a,b 1.3 (1.12-1.48)a,c 0.9 (0.8-1.1) 0.000**
n 292 30 28 350
BSR (mg/dl); Median (IQR) 95 (87–106.25)a 98.5 (85.7-117.75)a,b 104.5 (91.5-141)a,c 96 (87–111) 0.03*
n 290 30 28 348
HBA1C (%); Median (IQR) 5.3 (4.8-5.8)a 5.8 (4.9-6.02)a,b 5.65 (4.82-6.07)a,c 5.4 (4.8-5.8) 0.03*
n 288 30 28 346
Total CL (mg/dl); Median (IQR) 155.5 (138–184)a 148.5 (128–177.25)b 164 (138.5-220.75)c 155 (137–184) 0.3
n 292 30 28 350
HDL (mg/dl); Median (IQR) 40 (35–45)a 37.5 (31.75-42)a,b 42 (37–45)a,c 40 (34–45) 0.03*
n 292 30 27 349  
  1. a, b& cshows the significance difference between the groups. If any two or more groups have the same letters, there is significant difference between the groups.
  2. *p value < 0.05 and **p value < 0.0001, calculated using Kruskil Wallis test.
  3. IQR: Interquartile range (25th percentile – 75th percentile).